Compare FBRX & BDCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FBRX | BDCI |
|---|---|---|
| Founded | N/A | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 367.4M | 347.8M |
| IPO Year | N/A | 2025 |
| Metric | FBRX | BDCI |
|---|---|---|
| Price | $27.20 | $10.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $67.00 | N/A |
| AVG Volume (30 Days) | ★ 165.7K | 17.7K |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.90 | $10.01 |
| 52 Week High | $31.27 | $10.26 |
| Indicator | FBRX | BDCI |
|---|---|---|
| Relative Strength Index (RSI) | 64.83 | N/A |
| Support Level | $24.79 | N/A |
| Resistance Level | $29.33 | N/A |
| Average True Range (ATR) | 3.02 | 0.00 |
| MACD | -0.07 | 0.00 |
| Stochastic Oscillator | 64.96 | 0.00 |
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
BTC Development Corp is a blank check company.